Akums Drugs enters into license and distribution agreement with Triple Hair, Canada
News

Akums Drugs enters into license and distribution agreement with Triple Hair, Canada

Akums Drugs will undertake this development and commercialization in India

  • By IPP Bureau | October 16, 2024

Akums Drugs and Pharmaceuticals Limited has entered into a License & Distribution Agreement with  a company duly incorporated under the laws of New Brunswick, Canada, having its registered office at 5085 Principale-Est Av, Dieppe, New Brunswick, Canada.

As per the terms of the agreement, Akums Drugs has been granted the exclusive rights to further develop and market the products recently innovated by Triple Hair, in the Territory of India. Akums Drugs will undertake this development and commercialization after obtaining the necessary regulatory approvals or requisite licenses in India. The agreement grants Akums Drugs exclusive right to use Triple Hair's intellectual property rights (Patent) solely to carry out the studies and perform the services as stipulated in the agreement.

Further, Akums Drugs will manage the commercial strategy to promote and offer Triple Hair's patented products to its own marketing partners and clients within the Indian market exclusively.Triple Hair,

Other Related stories

Startup

Digitization

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International